
A Novo Nordisk-sponsored study of the cost-effectiveness of three different injectable anti-diabetes drugs has found Victoza is a cheaper option …

NICE will oversee the evaluation of Cancer Drugs Fund treatments in future, under new plans due for consultation by NHS …
The chief executive of NICE acknowledges changes are needed in how drugs are assessed in the UK – including more …
The Medical Research Council has awarded £2.3 million for new research into the academic methods underpinning advice given by NICE …
German Health Minister Philipp Rösler wants to break pharma’s ‘monopolistic hold’ over the country by introducing price limits on new …
Germany's Merck has the kind of business model that investors warm to during times of recession. The company is the …

